Bullboard Post History

by pmrider


V.BTI

TrancendPep - Implications

4.5 stars

On April 24th, biOasis came out with a PR with respect to our new...

10 days ago

V.BTI

Previous link didn't work. Try this

3.5 stars

Sorry, the link didn't work.  Try this process: http://www.aacr.org/home...

March 26, 2014

V.BTI

BT2111 Papers AACR Conference April 5-9

3.5 stars

Bioasis is presenting 3 papers at the AACR conference: http://www...

March 26, 2014

V.BTI

RE:RE:RE:RE:RE:Breaking through resistance $1.30 offer

4.5 stars

Outofthered: Of significance in the last NR, was the following statement...

March 6, 2014

V.BTI

Our Market & RMT

4.5 stars

Receptor Mediated Transcytosis technologies have been around for many years...

February 18, 2014

V.BTI

Roche & Scientific America Article

4.5 stars

Finally had the opportunity to have a "look under the hood" on Roche's brain...

January 15, 2014

V.BTI

RE:RE:Interesting Article on AstraZeneca/Medimmune

3 stars

Jekyl: You raise alot of interesting points and certainly the article is...

December 5, 2013

V.BTI

Interesting Article on AstraZeneca/Medimmune

5 stars

Here is a link to the article (apologize in advance if it has been discussed...

November 28, 2013

V.BTI

RE:AngioChem

3.5 stars

Hi BearDown: Over the years, there has been some debate over which receptor...

November 13, 2013

V.BTI

Initial take on the NR

3.5 stars

There is one point in the NR that about says it all: "Understanding the...

November 12, 2013

V.BTI

RE:Gazyva

3 stars

Kayaker: One would think that this would be something Roche would be...

November 1, 2013

V.BTI

Shire

3.5 stars

Shire has recently redone their website and included some interesting items...

October 22, 2013

V.BTI

RE:RE:Trastuzumab across the BBB

5 stars

Sniper: I think that Kayaker touched on the most important point - What else...

October 10, 2013

V.BTI

RE:preclinical deal

5 stars

For those of you that might think the quantity of NR's is directly...

August 26, 2013

V.BTI

RE:RE:to-BBB

0 stars

Sniper: I hope that tobbb is successful.  What this industry needs, is...

August 20, 2013

V.BTI

AstraZeneca Chief on Celltrion

1 star

Interesting commentary from Pascal Soriot on speculation of AZ acquiring...

August 12, 2013

V.BTI

RE:RE:RE:New Patent: Lysosomal Storage Disease:

0 stars

This patent issue would increase the value of the LSD franchise significantly...

August 7, 2013

V.BTI

RE:Trasncend, T-DM1 & Biosimilars

0 stars

In addition, you can add Novartis & Amgen to the list of other big pharma's...

August 5, 2013

V.BTI

Trasncend, T-DM1 & Biosimilars

0 stars

T-DM1 is a drug conjugate consisting of Herceptin & mertansine (potent...

August 5, 2013

V.BTI

RE:Armagen

0 stars

Absolutely remarkable given the University of Wisconsin study on Armagen...

July 18, 2013